Estrogen dose and progestogen type: Their effect on hemostatic changes in oral contraceptive users

Gynecological Endocrinology

Volumn 10, Issue SUPPL. 2, 1996, Pages 133-135

  Norris, L A ^a   Bonnar, J ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

Ethinylestradiol; Oral contraceptives; Progestogen; Thrombosis

Indexed keywords

EID: 0008278840     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513599609045644     Document Type: Article

References (7)

1. Sabra, A. and Bonnar, J. (1983). Haemostatic changes induced by 50 μg and 30 μg oestrogen/progestogen oral contraceptives. J. Reprod. Med., 28, 85-91
2. Meade, T.W. (1988). Risks and mechanisms of cardiovascular events in users of oral contraceptives. Am. J. Obstet. Gynccol., 158, 1646-52
3. Daly, L. and Bonnar, J. (1990). Comparative studies of 30 μg ethinyloestradiol combined with gestodene and desogestrel on blood coagulation, fibrinolysis and platelets. Am. J. Obstet. Gynecol., 163, 430-7
4. Basdevant, A., Conard, J., Pelissier, C., Guyene, T.T., Lapousterle, C., Mayer, M., Guy-Grand, B. and Degrelle, H. (1993). Haemostatic and metabolic effects of lowering the ethinyloestradiol dose from 30 μg to 20 μg in oral contraceptives containing desogestrel. Contraception, 48, 193-204
5. Melis, G.B., Fruzetti, F., Nicoletti, I., Ricci, C., Lammers, P., Atsma, W.J. and Fioretti, P. (1991). A comparative study on the effects of a monophasic pill containing desogestrel plus 20 μg ethinyloestradiol, a triphasic combination containing levonorgestrel and a monophasic combination containing gestodene on coagulatory factors. Contraception, 43(1), 23-31
6. Peterson, K.R., Sidelman, J., Skouby, S.O. and Jespersen, J. (1993). Effects of monophasic low dose oral contraceptives on fibrin formation and resolution in young women. Am. J. Obstet. Gynecol., 168, 32-8
7. Samsioe, G. (1994). Coagulation and anticoagulation effects of contraceptive steroids. Am. J. Obstet. Gynecol., 170, 1523-7